Disseminated on behalf of FendX Technologies Inc.
Keeping surfaces clean from germs and bacteria is a multi-billion dollar business, one that’s expected to grow as global travel and rapid urbanization increase the risk of infectious diseases. Since the 1970s roughly 40 new and potentially lethal pathogens have emerged including SARS, Ebola and MERS and COVID-19. More are expected in the coming decades.
Many of these pathogens are spread by coming into contact with surfaces in healthcare environments and other high-traffic venues. The existing coatings and disinfectants fall short, which is why some companies are investing in finding other potential solutions. A promising player among them is FendX Technologies Inc. FDXTF FNDX. Their lead product in development, REPELWRAP™ film, uses nanotechnology to prevent bacteria and viruses from adhering to its surface, reducing their spread. It works instantly and provides 2/47 protection. The subsequent spray that is in the works will have the added benefit of killing residual germs on the surface.
REPELWRAP™ Film is Unique And Potentially Disruptive
Other antimicrobial protective films on the market require pathogens to stick to the surface or be deactivated by light, which can take hours to work. That is a lot of time for germs to stick around and infect unsuspecting people. Regular disinfectants work, but only for a little while. Short of constantly spraying the surface, they aren’t enough.
That's why additional innovative solutions are being developed. According to the Centers for Disease Control, there are more than 99,000 deaths each year from healthcare-associated infections in the U.S., costing more than $28 billion in medical expenses annually in the U.S. to treat these infections. Healthcare-associated infections, most being antimicrobial resistant, are one of the top ten global public health threats according to the World Health Organization. By 2050, if left unchecked, it is forecast to be a leading cause of death for ten million people each year.
It's why antimicrobial surface technologies are seen as a potentially important way to limit the spread of pathogens that are the cause of infectious diseases and why the market size is projected to grow. By 2025, global revenue is expected to reach $7.6 billion, according to Future Markets, which presents a significant opportunity for FendX with its potential future protective coating products.
Instantly Repels, Doesn’t Collect Germs
FendX is taking the approach of developing surface coatings that repel germs, preventing them growing on the surface coating and significantly reducing their spread. Inspired by water-resistant lotus leaves, FendX’s nanotechnology is textured with nanoscopic wrinkles that repel water, blood, viruses and bacteria. Their surface coatings in development provide instant and continuous protection that does not promote antimicrobial resistance. High surface tension and low surface tension liquids like water and oil form droplets when they come into contact with the surface coating.
The results demonstrated in McMaster’s lab are promising. They show a reduction of > 99% adhesion of COVID-19-like viruses and bacteria like MRSA, and the spray formulation provides additional protection beyond the 99% by reducing bacterial growth caused by any residual bacteria on the surface.
The spread of bacteria and viruses that cause infectious diseases is difficult to control, and it's predicted to only get worse driven by global travel and migration to cities. Protecting the spread requires innovative solutions, and FendX is focused on developing its lotus leaf-inspired coatings with the intention to positively contribute to fighting this growing and potentially deadly problem.
Featured photo by National Cancer Institute on Unsplash.
This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice. Please refer to the following link: https://investinginsider.com/reports/unlock-the-secrets-of-the-lotus-leaf#disclaimer for the assumptions and risks associated with such forward-looking information.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.